Teligent Other Non-Current Liabilities 2010-2021 | TLGT
Teligent other non-current liabilities from 2010 to 2021. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Teligent Annual Other Non-Current Liabilities
(Millions of US $) |
| 2020 |
$12 |
| 2019 |
$9 |
| 2018 |
$0 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Teligent Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$12 |
| 2020-09-30 |
$9 |
| 2020-06-30 |
$8 |
| 2020-03-31 |
$10 |
| 2019-12-31 |
$9 |
| 2019-09-30 |
$2 |
| 2019-06-30 |
$2 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
$0 |
| 2018-09-30 |
$0 |
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-09-30 |
$0 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
$0 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$0 |
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
